PMV Pharmaceuticals, Inc. (PMVP) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts PMVP Hot Sheet
Join SI Premium – FREE
PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q2 EPS of ($0.38), $0.11 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $0.
For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- Bernstein SocGen on StandardAero Inc (SARO): ' Solid revenues, but short-term margin issues'
- DA Davidson Reiterates Buy Rating on Wabash National (WNC)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
